所谓的“全球协议”，不过是药企的利润围墙The 'Global Treaty' is Just a Profit Wall for Big Pharma
这篇新闻读起来像是一场关于“人性”和“承诺”的感人呼吁，但剥开 Lula 和 WHO 的温情叙事，核心冲突极其简单：药企想要垄断，而穷国想要生存。这就是典型的 structural violence。在加尔通的暴力三角里，这种制度性的资源分配不均，其杀伤力并不亚于直接的谋杀。
所谓的“协议”卡在那个关于“病原体获取与利益分享”的附件上。翻译成白话就是：发展中国家提供病毒样本（数据），药企用这些样本研发疫苗（利润），然后药企决定谁能买得起疫苗（权力）。药企代表说强制分享会“扼杀研发”，这简直是最大的 scam。研发的动力从来不是为了“拯救人类”，而是为了在专利墙内通过定价权榨干每一个生命。这种以“创新”为名的解释权垄断，正是元暴力的体现。
五个年头过去了，协议还没签成。这证明了在 global governance 的博弈中，药企的 profit 永远高于底层人口的 potential survival。那些在玻璃窗后告别的家庭，成了政治人物用来敲门的情感筹码，但只要药企的利益分配机制不被强制拆除，下一个 pandemic 依然会精准地在穷国制造死亡，在富国制造利润。
这种协议如果最终通过某种“妥协”达成，大概率又是另一种 PR 版本的 structural violence——给一点施舍，但保留所有定价权。
This news reads like a touching plea for 'humanity' and 'promises,' but stripping away the sentimental narrative of Lula and the WHO reveals a brutal core: Big Pharma wants monopoly, and poor nations want survival. This is textbook structural violence. In the Violence Triangle, this institutional inequality in resource distribution is as lethal as direct murder.
The 'treaty' is stuck on an annexe regarding 'pathogen access and benefit sharing.' In plain English: developing nations provide virus samples (data), pharma companies use them to develop vaccines (profit), and pharma companies decide who can afford them (power). Industry representatives claim mandatory sharing would 'stifle R&D'—a complete scam. The drive for R&D has never been about 'saving humanity,' but about extracting maximum value through pricing power within patent walls. This monopoly over the right to interpret 'innovation' is a manifestation of meta-violence.
Five years have passed, and the deal is still not signed. This proves that in the game of global governance, pharma profits always outweigh the potential survival of the global poor. The families saying goodbye through glass have become emotional chips for politicians, but as long as the profit distribution mechanism remains voluntary, the next pandemic will once again produce deaths in poor nations and dividends in rich ones.
If this treaty is eventually signed through some 'compromise,' it will likely be another PR version of structural violence—offering crumbs of charity while retaining total pricing power.